These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20699504)
1. Peritumoral lymphatic vessel density as a prognostic parameter in endometrial carcinoma: an immunohistochemical study. Maghraby HK; Elsarha AI; Saad RS Indian J Pathol Microbiol; 2010; 53(3):465-9. PubMed ID: 20699504 [TBL] [Abstract][Full Text] [Related]
2. Lymphatic vessel density as a prognostic marker in clinical stage I endocervical adenocarcinoma. Saad RS; Ismiil N; Ghorab Z; Nofech-Mozes S; Dubé V; Covens A; Khalifa MA Int J Gynecol Pathol; 2010 Jul; 29(4):386-93. PubMed ID: 20567154 [TBL] [Abstract][Full Text] [Related]
3. Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma. Saad RS; Lindner JL; Liu Y; Silverman JF Am J Clin Pathol; 2009 Jan; 131(1):92-8. PubMed ID: 19095571 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ Am J Clin Pathol; 2008 Apr; 129(4):578-86. PubMed ID: 18343785 [TBL] [Abstract][Full Text] [Related]
5. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297 [TBL] [Abstract][Full Text] [Related]
6. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer. Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262 [TBL] [Abstract][Full Text] [Related]
7. Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases. Braun M; Wardelmann E; Debald M; Walgenbach-Bruenagel G; Höller T; Wolfgarten M; Sauerwald A; Rudlowski C; Büttner R; Kuhn W; Pölcher M Onkologie; 2009 Dec; 32(12):732-8. PubMed ID: 20016234 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Lymphatic Vessel Density Detected by D2-40 and Its Relation to Claudin-4 Expression in Prostatic Adenocarcinoma. Radi DA; Abd-Elazeem MA Int J Surg Pathol; 2016 May; 24(3):219-26. PubMed ID: 26464161 [TBL] [Abstract][Full Text] [Related]
9. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma. Coşkun U; Akyürek N; Dursun A; Yamaç D J Surg Res; 2010 Nov; 164(1):110-5. PubMed ID: 19628230 [TBL] [Abstract][Full Text] [Related]
10. Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Walgenbach-Bruenagel G; Tolba RH; Varnai AD; Bollmann M; Hirner A; Walgenbach KJ Eur Surg Res; 2006; 38(5):438-44. PubMed ID: 16912482 [TBL] [Abstract][Full Text] [Related]
11. Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma. Imamura Y; Watanabe M; Nagai Y; Baba Y; Hirashima K; Karashima R; Iwatsuki M; Yoshida N; Kinoshita K; Kurashige J; Iyama K; Baba H J Surg Oncol; 2012 Mar; 105(3):277-83. PubMed ID: 22271500 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer. Xiong Y; Cao LP; Rao HL; Cai MY; Liang LZ; Liu JH Cell Tissue Res; 2012 Jun; 348(3):515-22. PubMed ID: 22492093 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Barresi V; Reggiani Bonetti L; Vitarelli E; Di Gregorio C; Ponz de Leon M; Barresi G Am J Surg Pathol; 2012 Jan; 36(1):66-72. PubMed ID: 21989343 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients. Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035 [TBL] [Abstract][Full Text] [Related]
15. Lymphatic vessel densities of lymph node-negative prostate adenocarcinoma in Korea. Kim HS; Sung W; Lee S; Chang SG; Park YK Pathol Res Pract; 2009; 205(4):249-54. PubMed ID: 19058917 [TBL] [Abstract][Full Text] [Related]
16. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis. Bolenz C; Fernández MI; Trojan L; Hoffmann K; Herrmann E; Steidler A; Weiss C; Ströbel P; Alken P; Michel MS BJU Int; 2009 Apr; 103(8):1040-6. PubMed ID: 18990139 [TBL] [Abstract][Full Text] [Related]
17. The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers. Afonso J; Santos LL; Amaro T; Lobo F; Longatto-Filho A Histopathology; 2009 Nov; 55(5):514-24. PubMed ID: 19912357 [TBL] [Abstract][Full Text] [Related]
18. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium. Niakosari F; Kahn HJ; Marks A; From L Arch Dermatol; 2005 Apr; 141(4):440-4. PubMed ID: 15837861 [TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma]. Fan YZ; Li GM; Huang GP; Li XP Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789 [TBL] [Abstract][Full Text] [Related]
20. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point. Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]